… The SPLF, considering the evolution of COPD treatment paradigms and the constantly … its
position on how to optimise pharmacological therapy in patients with COPD. This update was …

… In this context, the SPLF decided to update its position on pharmacological treatment
optimization in stable COPD in 2021. A working group expert in COPD, representative of …

… of COPD, including current and emerging pharmacological treatment options, and identify
steps for optimising early diagnosis and pharmacological treatment of COPD within the …

The number of pharmacological treatments available for COPD has increased markedly in
the last years, mostly corresponding to new agents, combinations and devices within know …

… of COPD and risk of exacerbations. The goals of the treatment in stable COPD include …
: facilitate smoking cessation; optimise pharmacotherapy; assist with early identification and …

… chronic obstructive pulmonary disease (COPD) have emerged in recent years, patients with
severe COPD … try to provide a personalised treatment for every severe COPD patient. In this …

… Do not routinely use mucolytic drugs to prevent exacerbations in people with stable COPD.
The guidelines give clear guidance on avoiding possible inappropriate use of mucolytics in …

… IV disease whose symptoms are not controlled despite optimisation of their bronchodilator
treatment, or if a reversible (asthmatic) component to the COPD is thought to be present. This …

… treatment of COPD a holistic approach should be taken. In order to reach this, an individual
treatment … at least elements of smoking cessation, optimisation of pulmonary status by …

… chronic obstructive pulmonary disease. Proposals from the Société de Pneumologie de
Langue FrançaiseOptimisation … chronique obstructive en état stable. Propositions de la Société …